[Pathogenetic bases of epileptogenesis in cerebral cavernomas]

Area of Science:

• Neuroscience
• Pathology
• Vascular Biology

Context:

• Brain cavernoma, a type of arteriovenous malformation, can lead to seizures, neurological deficits, or bleeding.
• The pathophysiology of seizures in cavernoma may involve hypoxia, neoangiogenesis, and metalloproteinases.
• Understanding the molecular mechanisms underlying cavernoma-associated seizures is crucial for potential therapeutic targets.

Purpose:

• To investigate the potential relationship between hypoxia and metalloproteinase expression and seizures in brain cavernoma patients.
• To analyze the immunohistochemical expression of hypoxia-inducible factor (HIF-1alpha) and matrix metalloproteinase-9 (MMP-9) in peritumoral tissues.
• To evaluate the correlation between HIF-1alpha and MMP-9 expression and the clinical presentation of seizures in a cohort of cavernoma patients.

Summary:

• Seventeen patients with anatomopathologically diagnosed brain cavernoma were analyzed using immunohistochemical staining for HIF-1alpha and MMP-9.
• A positive trend was observed between seizures and the presence of HIF-1alpha and MMP-9 in vascular endothelium, fibrous tissue, and brain tissue surrounding the cavernoma.
• Specifically, MMP-9 showed high positivity in vascular endothelium (86%) and fibrous tissue (100%), while HIF-1alpha was noted in vascular endothelium (31%) and brain tissue (34%) in seizure cases.

Impact:

• The findings suggest that HIF-1alpha and MMP-9 are associated with seizures, a common complication of brain cavernoma.
• This study provides immunohistochemical evidence linking specific molecular markers to the clinical manifestation of seizures in cavernoma.
• These results may contribute to a better understanding of cavernoma pathophysiology and potentially guide future diagnostic or therapeutic strategies.